CHEVY CHASE, Md.--(BUSINESS WIRE)--

Precision for Medicine, Inc. (Precision) today announced that Vicki Seyfert-Margolis PhD has joined the company as Chief of Science and Strategy. Dr. Seyfert-Margolis joins Precision from the U.S. Food and Drug Administration (FDA) where she served as Senior Advisor, Regulatory Science and Innovation, reporting to the Commissioner. In that role, Dr. Seyfert-Margolis was responsible for spearheading the FDAs regulatory science and personalized medicine initiative, the agencys strategy for promoting innovative approaches in drug development, strategies for big data and scientific computing, as well as policies and guidance for companion diagnostics and co-development. Prior to the FDA, Dr. Seyfert-Margolis was Chief Science Officer at the Immune Tolerance Network, a global research initiative to discover biomarkers for autoimmune disorders.

We are proud to have Vicki join the Precision leadership team, said Mark P. Clein, President. She brings a rare combination of scientific credibility, industry expertise, and an intimate understanding of the factors that are driving modern regulatory decision-making, innovation, and policy. She will play a critical role in guiding our scientific strategy and providing insight and support for our clients.

Precision for Medicine shares my vision for the future of health care one where the patient is not just the end user, but the focal point of all aspects of drug, diagnostic, and device development, said Dr. Seyfert-Margolis. The patient becomes central throughout the product lifecycle. Real world information will be as important as sequencing in developing targeted medications and identifying the best treatment paradigms. I am excited to help build what is truly a next generation service company to support the innovators of tomorrows medical products.

About Precision for Medicine

Precision for Medicine is a specialized service company providing services and infrastructure to support life science companies as they develop new products in the age of precision medicine. Precision brings expertise, technology, and project execution to support innovative, patient centric solutions from discovery through commercialization. The company is headquartered in Chevy Chase, MD with offices in Gaithersburg, MD, Frederick, MD and Cambridge, MA. For more information about Precision, visitwww.precisionformedicine.com.

Read this article:

Precision for Medicine, Inc. Appoints Former FDA Advisor Vicki Seyfert-Margolis as Chief of Science and Strategy